SCHEMBL15112044

SCHEMBL15112044

Cn1c(CC(C)(C)C)nc2ccc(-n3ccc(OCc4ccc(Cl)cc4)cc3=O)cc21

nearest known ligand 0.68

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 20/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15112434 0.91 MCHR1 (0.81) MCHR1
SCHEMBL15111869 0.90 MCHR1 (0.65) MCHR1
SCHEMBL15111886 0.89 MCHR1 (0.82) MCHR1
SCHEMBL15111885 0.89 MCHR1 (0.70) MCHR1
SCHEMBL15112447 0.88 MCHR1 (0.63) MCHR1
SCHEMBL15112293 0.88 MCHR1 (0.82) MCHR1
SCHEMBL15112084 0.87 MCHR1 (0.68) MCHR1
SCHEMBL15111932 0.86 MCHR1 (0.68) MCHR1
SCHEMBL15111890 0.85 MCHR1 (0.81) MCHR1
SCHEMBL15112241 0.85 MCHR1 (0.67) MCHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9365540-B2 Benzimidazole derivatives as MCH receptor antagonists TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2016-06-14 US disclosed
US-9365540-B2 Benzimidazole derivatives as MCH receptor antagonists TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2016-06-14 US disclosed
US-9365540-B2 Benzimidazole derivatives as MCH receptor antagonists TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2016-06-14 US disclosed
EP-2802571-A1 BENZIMIDAZOLE DERIVATIVES AS MCH RECEPTOR ANTAGONISTS Takeda Pharmaceutical Company Limited (JP) 2014-11-19 EP disclosed
WO-2013105676-A1 BENZIMIDAZOLE DERIVATIVES AS MCH RECEPTOR ANTAGONISTS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-07-18 WO disclosed